ClinConnect ClinConnect Logo
Search / Trial NCT07078188

The Effect of PEG Use Education on the Care Burden and Quality of Life of Patients' Relatives

Launched by ULUDAG UNIVERSITY · Jul 12, 2025

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Palliative Care Nutrition Peg Caregiver Caregiver Burden Quality Of Life Peg Training

ClinConnect Summary

This clinical trial is studying how teaching family members to use a feeding tube called a PEG (Percutaneous Endoscopic Gastrostomy) before a patient leaves the hospital affects the stress and quality of life of those who care for palliative care patients. Palliative care means care focused on comfort for people with serious illnesses. The study wants to see if this training helps caregivers feel more confident and less overwhelmed while improving their overall well-being.

To take part, caregivers need to be adults who are primarily responsible for a patient over 18 who receives palliative care and uses a PEG feeding tube, especially if the patient had a stroke at least six months ago. Caregivers also need to be mentally and emotionally ready to provide care and not have serious health or mental health issues. Participants will have face-to-face interviews at the start, after one month, and after three months. Only the group receiving the training will get education about PEG use at the first meeting. During the study, caregivers will fill out simple questionnaires about their stress, burden, and quality of life. This study aims to help families better manage care and improve their daily lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The caregiver must be over 18 years old
  • The caregiver must be willing and able to participate in the study
  • The caregiver must be primarily responsible for the patient's care
  • The patient they are caring for must be receiving palliative care
  • The patient they are caring for must be receiving PEG feeding
  • The patient they are caring for must be over 18 years old
  • The patient they are caring for must have been diagnosed with stroke at least six months ago
  • The caregiver must have a mini mental test score of 25 points or more
  • The Beck depression scale score must be under 17 points
  • The caregiver must have a score of over 16 points on the Readiness to Provide Care Scale
  • Exclusion Criteria:
  • The caregiver is under the age of 18
  • The caregiver is not willing and able to participate in the research
  • The caregiver has a physical disability or serious health problem that makes it difficult to provide care
  • The patient they are caring for is under the age of 18
  • The patient they are caring for has been diagnosed with cancer, endocrine system or GI disease
  • The caregiver has a mini mental test score of less than 25
  • The Beck depression scale score is 17 points or higher
  • The caregiver has scored 16 or lower on the Readiness to Provide Care Scale
  • The caregiver has communication problems
  • The caregiver has been diagnosed with depression or psychiatric disorder
  • The caregiver is receiving psychotherapy/psychological support
  • The caregiver is taking antidepressants and/or anxiolytics
  • The caregiver has sensory loss related to vision and hearing

About Uludag University

Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.

Locations

İstanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Hicran Yıldız, Prof.Dr.

Principal Investigator

Bursa Uludag Unversity

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported